Copenhagen, Denmark; June 8, 2006 – Pursuant to Section
28a of the Danish Securities Trading Act, Genmab A/S (CSE: GEN) shall make
public information on transactions by managerial employees and their
related parties involving Genmab shares and related instruments, as
follows:
|
Name
|
Jan van de Winkel
|
|
Reason
|
Executive Vice President & Chief Scientific Officer
|
|
Issuer
|
Genmab A/S
|
|
ID code/ ISIN
|
DK 0010272202
|
|
Description
|
Shares
|
|
Transaction
|
Purchase
|
|
Trading date
|
June 8, 2006
|
|
Market
|
Copenhagen Stock Exchange
|
|
Number
|
20,000
|
|
Market value
|
DKK 3,400,000
|